Sector Charles River Laboratories International, Inc.
Aandelen
CRL
US1598641074
Biotechnologie & Medisch Onderzoek
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 232,51 USD | -0,90% |
|
+2,62% | +16,56% |
| 29/07 | Align Technology breidt bestuur uit en start evaluatie na akkoord met Elliott | RE |
| 13/07 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : BofA Securities geeft koopadvies | ZM |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,90% | +2,62% | +2,52% | +39,25% | +16,56% | +37,06% | +10,96% | -42,86% | +164,43% | 11,3 mld. | |
| -1,40% | +2,59% | +3,00% | +17,32% | +4,54% | -1,71% | +11,28% | -20,28% | +207,72% | 49,37 mld. | |
| -2,41% | -0,90% | +0,13% | +30,12% | +135,44% | +403,17% | +614,40% | +554,78% | - | 40,85 mld. | |
| -1,16% | +12,96% | +21,63% | +48,40% | +4,26% | +26,45% | +5,03% | -5,12% | +202,70% | 39,14 mld. | |
| -1,88% | -3,03% | +10,89% | +7,02% | +4,02% | +4,94% | +47,52% | -0,18% | +1.104,31% | 35,81 mld. | |
| -1,74% | +5,12% | +7,73% | -2,23% | +8,31% | +9,58% | +46,02% | -10,42% | +155,22% | 30,5 mld. | |
| -2,85% | -3,92% | -8,55% | +6,33% | - | - | - | - | - | 16,55 mld. | |
| -0,21% | -4,04% | +8,97% | +37,85% | +2,75% | +35,09% | +127,95% | +228,02% | - | 16,14 mld. | |
| -0,64% | +2,65% | -0,58% | +15,49% | +9,23% | +1,25% | +8,92% | -32,41% | +103,19% | 13,71 mld. | |
| -1,19% | -1,32% | -5,84% | +38,23% | -10,24% | -3,32% | -34,94% | -32,76% | +110,59% | 12,77 mld. | |
| +0,08% | +0,68% | +2,04% | +30,31% | +22,58% | +31,72% | -13,56% | -40,20% | +156,50% | 11,22 mld. | |
| -2,03% | -5,76% | -7,97% | +10,21% | -11,71% | +66,09% | +506,74% | +253,74% | +2.461,45% | 10,77 mld. | |
| -0,16% | -0,14% | +1,02% | +61,77% | +77,65% | +250,47% | +526,59% | - | - | 10,08 mld. | |
| -1,44% | +0,39% | +11,47% | +38,06% | +56,45% | +153,69% | +604,33% | +176,43% | - | 8,92 mld. | |
| +2,19% | -4,49% | +27,20% | +25,55% | +29,44% | +18,33% | +30,04% | -58,18% | - | 8,9 mld. | |
| -2,83% | -8,45% | -34,71% | -30,75% | -34,56% | +20,45% | +24,96% | +39,39% | +77,36% | 8,85 mld. | |
| -3,37% | -6,48% | -9,83% | +27,54% | +32,89% | +136,34% | +372,58% | +71,82% | - | 8,8 mld. | |
| +0,03% | -5,37% | -8,05% | -3,45% | +4,44% | +467,74% | +1.972,72% | +31,55% | - | 8,58 mld. | |
| -0,12% | +0,07% | +5,88% | +19,72% | -12,54% | -20,29% | -20,78% | -29,74% | +33,27% | 8,57 mld. | |
| -2,08% | -7,37% | -6,50% | +45,33% | +75,09% | +84,94% | +67,32% | +89,37% | -1,82% | 8,39 mld. | |
| Gemiddelde | -1,21% | -0,86% | +1,02% | +23,10% | +21,82% | +90,63% | +258,32% | +65,16% | +397,91% | 17,96 mld. | |
| Gewogen gemiddelde per kap. | -1,41% | +1,44% | +3,90% | +22,70% | +25,59% | +87,28% | +198,16% | +85,85% | +400,83% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
